New Key Statistics Module, Z-Score and F-Score
OTCPK:SHTDF Key Ratios
| Market Cap $ M | 6,245.14 |
| Enterprise Value $ M | 21,270.83 |
| P/E(ttm) | 6.12 |
| PE Ratio without NRI | 5.26 |
| Forward PE Ratio | 5.88 |
| Price/Book | 0.50 |
| Price/Sales | 0.08 |
| Price/Free Cash Flow | 3.44 |
| Price/Owner Earnings | 5.92 |
| Payout Ratio % | 0.26 |
| Revenue (TTM) $ M | 82,786.00 |
| EPS (TTM) $ | 0.33 |
| Beneish M-Score | -2.44 |
| 10-y EBITDA Growth Rate % | 5.00 |
| 5-y EBITDA Growth Rate % | -7.20 |
| y-y EBITDA Growth Rate % | -17.60 |
| EV-to-EBIT | 8.91 |
| EV-to-EBITDA | 8.91 |
| PEG | -- |
| Shares Outstanding M | 3,120.66 |
| Net Margin (%) | 1.24 |
| Operating Margin % | 2.92 |
| Pre-tax Margin (%) | 2.54 |
| Quick Ratio | 1.14 |
| Current Ratio | 1.40 |
| ROA % (ttm) | 1.77 |
| ROE % (ttm) | 8.62 |
| ROIC % (ttm) | 5.84 |
| Dividend Yield % | 4.68 |
| Altman Z-Score | 2.24 |
SHTDF Number of Guru Trades
SHTDF Volume of Guru Trades
Gurus Latest Trades with OTCPK:SHTDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SHTDF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sinopharm Group Co Ltd Insider Transactions
No Available Data
News about OTCPK:SHTDF
Total 0- 1